Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

STEP-CD study: ustekinumab use in paediatric Crohn's disease-a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN.

European journal of pediatrics·2024
Same author

Unfermented β-fructan Fibers Fuel Inflammation in Select Inflammatory Bowel Disease Patients.

Gastroenterology·2022
Same author

Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed-up Study): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN.

Journal of pediatric gastroenterology and nutrition·2022
Same author

Outcomes and Predictors of Sustained Remission After Drug Withdrawal in Pediatric Crohn Disease.

Journal of pediatric gastroenterology and nutrition·2022
Same author

Metabolome Changes With Diet-Induced Remission in Pediatric Crohn's Disease.

Gastroenterology·2022
Same author

IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2022

Related Experiment Video

Updated: Jun 20, 2026

A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium
04:05

A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium

Published on: May 31, 2024

Pediatric inflammatory bowel disease: is it different?

Arie Levine1

  • 1Pediatric Gastroenterology and Nutrition Unit, Wolfson Medical Center, Tel Aviv University, Tel Aviv 58100, Israel. alevine@wolfson.health.gov.il

Digestive Diseases (Basel, Switzerland)
|September 30, 2009
PubMed
Summary
This summary is machine-generated.

Pediatric inflammatory bowel disease, including Crohn's disease (CD) and ulcerative colitis (UC), presents differently than adult-onset disease. Pediatric patients often have more extensive disease, increased severity, and a higher likelihood of upper gastrointestinal involvement.

More Related Videos

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

Related Experiment Videos

Last Updated: Jun 20, 2026

A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium
04:05

A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium

Published on: May 31, 2024

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

Area of Science:

  • Gastroenterology
  • Pediatric Medicine
  • Inflammatory Bowel Disease (IBD) research

Background:

  • Clinical manifestations of Crohn's disease (CD) and ulcerative colitis (UC) exhibit significant phenotypic diversity.
  • Age of onset is a key factor influencing disease presentation and natural history in IBD.
  • Pediatric-onset IBD may differ substantially from adult-onset IBD, impacting disease management strategies.

Purpose of the Study:

  • To compare the clinical phenotypes of pediatric-onset versus adult-onset inflammatory bowel disease (IBD).
  • To identify key differences in disease presentation, extent, and severity between pediatric and adult patients with CD and UC.
  • To highlight the unique aspects of pediatric IBD that necessitate tailored management approaches.

Main Methods:

  • Comparative analysis of clinical data from pediatric and adult IBD cohorts.
  • Phenotypic characterization based on disease extent, severity, and age of onset.
  • Review of existing literature comparing adult and pediatric IBD presentations.

Main Results:

  • Pediatric-onset ulcerative colitis (UC) frequently presents as pancolitis (60-70% of cases) compared to adult-onset UC (20-30%).
  • Pediatric patients with UC are more prone to severe disease and steroid dependence.
  • Crohn's disease (CD) shows an inverse relationship with age; younger children are more likely to have colonic CD and upper gastrointestinal involvement.
  • Growth failure in pediatric IBD patients indicates a high-risk group for complications.

Conclusions:

  • Significant differences exist in the phenotype of pediatric versus adult-onset ulcerative colitis and Crohn's disease.
  • Pediatric IBD patients often exhibit more extensive and severe disease, including upper GI involvement and growth issues.
  • Recognizing these pediatric-specific phenotypes is crucial for effective disease management and improving patient outcomes.